The Dow Jones Industrial Average (DJI) is giving back earlier gains this afternoon, dropping over 238 points. The Nasdaq Composite (IXIC) and S&P 500 Index (SPX), meanwhile, are struggling for direction, though both indexes were last seen well above breakeven. The major benchmarks are also pacing for sizable weekly drops, though all three are set to notch modest monthly wins. The 10-year Treasury yield is still close to 1.5%, alarming many on Wall Street, though there seems to be some optimism over a 0.3% monthly rise in the personal consumption expenditures (PCE) price index -- an indicator of muted inflation for January. 

Cloudera Inc (NYSE: CLDR) is seeing an unusual amount of bearish activity in its options pits. So far, 2,895 puts have crossed the tape -- two times the intraday average, and nearly double the number of calls exchanged. The most popular is the March 12 put, where positions are being bought-to-open. The equity is up 0.4% at $16.16 at the last check, erasing earlier losses, though a reason for the volatile price action remains unclear. Now, CLDR is attempting to snap a four-day losing streak, and remains up over 16% in 2021, with support at the 40-day moving average containing today's short-lived pullback. 

One of the best-performing stocks on the New York Stock Exchange (NYSE) today is Xtant Medical Holdings Inc (NYSE: XTNT). The equity is up 105.7% to trade at $3.96 at last check, and earlier hit a two-year high of $4.49. The company yesterday announced the closing of its $20 million private placement to a single healthcare-focused investor. Over the last few months, the security has been climbing up the charts, with recent support at its 30-day moving average guiding the shares higher. 

One of the worst stocks on the Nasdaq today is Tricadia Inc (Nasdaq: TCDA). The security is down 29.3% at $5.20 at last check, after the Office of New Drugs (OND) of the Food and Drug Administration (FDA) denied an appeal in response to its Formal Dispute Resolution Request (FDRR), submitted in December 2020. Tricadia stock is trading at its lowest level since late October and now carries a 25.8% year-to-date deficit.